Ptc Therapeutics, Inc. Income Statement

Income Statement Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 105.41M33.95M34.70M25.25M36.77M82.70M194.39M264.73M306.98M380.77M538.59M698.80M937.82M806.78M
Cost of Revenue 4.58M12.67M12.13M18.94M32.33M44.68M65.49M57.40M
Gross Profit 105.41M33.95M34.70M25.25M36.77M82.70M189.81M252.06M294.85M361.82M506.26M654.12M872.34M749.38M
Operating items
Amortization - Intangibles 15.40M22.90M27.70M36.90M54.80M116.60M222.63M60.74M
Depreciation & Amortization - Total 3.30M2.30M2.60M
Research & Development 58.68M46.14M54.88M79.84M121.82M117.63M117.46M171.98M257.45M477.64M540.68M651.50M666.56M534.48M
Selling, General & Administrative 16.15M14.62M25.22M44.82M82.08M97.13M121.27M153.55M202.54M245.16M285.77M326.00M332.54M300.91M
Other Operating Expenses -3.30M17.66M-19.34M-48.36M-23.28M0.50M25.90M127.70M4.47M
Operating Expenses 74.83M60.75M80.09M124.66M203.90M214.76M258.68M380.42M548.14M812.53M913.04M1146.21M1377.32M1109.35M
Operating Income 30.58M-26.81M-45.40M-99.41M-167.13M-132.06M-64.29M-115.69M-241.16M-431.77M-374.44M-447.41M-439.50M-302.57M
EBIT 30.58M-26.81M-45.40M-99.41M-167.13M-132.06M-64.29M-115.69M-241.16M-431.77M-374.44M-447.41M-439.50M-302.57M
Non-operating items
Interest & Investment Income -2.44M-1.21M-6.08M1.18M-2.37M-8.28M-12.09M-12.55M-12.49M-56.35M-86.02M-90.87M-129.18M-166.99M
Other Non Operating Income 0.46M1.78M-0.13M-0.21M-0.47M-1.21M-1.28M0.13M13.72M85.19M-57.88M-49.21M-137.56M6.54M
Non Operating Income 0.46M1.78M0.04M-0.21M-0.47M-1.21M-1.28M-0.74M13.72M85.19M-57.88M-49.21M10.13M6.54M
Net income details
EBT 28.60M-26.23M-51.57M-98.45M-169.96M-141.54M-77.67M-128.11M-239.93M-452.48M-518.34M-591.13M-784.74M-598.81M
Tax Provisions -2.31M-4.69M0.48M0.57M1.33M0.67M11.65M35.23M5.56M-28.47M-69.51M26.80M
Profit After Tax 30.90M133.34M-66.43M-93.75M-170.45M-142.11M-79.00M-128.08M-251.58M-438.16M-523.90M-559.02M-626.60M-363.30M
Income from Continuing Operations 30.90M-26.23M-51.57M-93.75M-170.45M-142.11M-79.00M-128.78M-251.58M-487.70M-523.90M-562.66M-715.24M-625.61M
Consolidated Net Income 30.90M-26.23M-51.57M-93.75M-170.45M-142.11M-79.00M-128.78M-251.58M-487.70M-523.90M-562.66M-715.24M-625.61M
Income towards Parent Company 30.90M-26.23M-51.57M-93.75M-170.45M-142.11M-79.00M-128.78M-251.58M-487.70M-523.90M-562.66M-715.24M-625.61M
Net Income towards Common Stockholders 30.90M-26.23M-51.57M-93.75M-170.45M-142.11M-79.00M-128.78M-251.58M-438.16M-523.90M-559.02M-626.60M-363.30M
Additional items
EPS (Basic) 0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 22.21M24.92M33.60M34.27M34.32M41.49M50.45M61.63M68.24M70.70M71.88M75.46M77.13M
Shares Outstanding (Diluted Average) 58.86M66.03M70.47M71.73M74.84M76.85M
EBITDA 30.58M-26.81M-45.40M-99.41M-167.13M-128.76M-61.99M-113.08M-241.16M-431.77M-374.44M-447.41M-439.50M-302.57M
Tax Rate 4.77%4.82%8.86%